Equity Rank covers 194 Biotechnology companies; 62 have a published model fair value, and 22 of those (35%) trade below the model estimate. The median model fair value sits 6.2% below the current price, under these model assumptions. Data as of 2026-10-22.
| Ticker | Company | Price | Model fair value | Gap |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | $535.17 | $492.46 | -8.0% |
| MRNA | Moderna Inc | $202.62 | Not published | — |
| REGN | Regeneron Pharmaceuticals Inc | $819.09 | $1024.52 | +25.1% |
| ARGX | argenx NV ADR | $875.76 | $879.29 | +0.4% |
| ONC | BeiGene, Ltd. | $383.08 | $258.78 | -32.5% |
| RVMD | Revolution Medicines Inc | $187.69 | Not published | — |
| RPRX | Royalty Pharma Plc | $63.75 | $43.42 | -31.9% |
| ALNY | Alnylam Pharmaceuticals Inc | $227.28 | $220.56 | -3.0% |
| GMAB | Genmab AS | $40.00 | $43.74 | +9.3% |
| INCY | Incyte Corporation | $116.93 | $194.25 | +66.1% |
| BNTX | BioNTech SE | $89.67 | Not published | — |
| INSM | Insmed Inc | $95.06 | Not published | — |
| EXEL | Exelixis Inc | $65.31 | $76.32 | +16.9% |
| ASND | Ascendis Pharma AS | $242.99 | Not published | — |
| HALO | Halozyme Therapeutics Inc | $124.54 | $84.01 | -32.5% |
| JAZZ | Jazz Pharmaceuticals PLC | $214.65 | $241.79 | +12.6% |
| BBIO | BridgeBio Pharma Inc | $68.07 | Not published | — |
| SMMT | Summit Therapeutics PLC | $15.55 | Not published | — |
| CORT | Corcept Therapeutics Incorporated | $107.50 | $88.62 | -17.6% |
| TECH | Bio-Techne Corp | $72.62 | $39.57 | -45.5% |
| BMRN | Biomarin Pharmaceutical Inc | $56.63 | $50.67 | -10.5% |
| MDGL | Madrigal Pharmaceuticals Inc | $453.34 | $408.32 | -9.9% |
| PCVX | Vaxcyte Inc | $62.85 | Not published | — |
| KRYS | Krystal Biotech Inc | $320.13 | $202.30 | -36.8% |
| TWST | Twist Bioscience Corp | $135.47 | Not published | — |
| KYMR | Kymera Therapeutics Inc | $110.85 | Not published | — |
| IBRX | Immunitybio Inc | $8.31 | Not published | — |
| PTGX | Protagonist Therapeutics Inc | $139.53 | $122.42 | -12.3% |
| CYTK | Cytokinetics Inc | $62.33 | Not published | — |
| CAI | Caris Life Sciences, Inc. Common Stock | $31.71 | $30.29 | -4.5% |
| SYRE | Spyre Therapeutics Inc. | $92.33 | Not published | — |
| AXSM | Axsome Therapeutics Inc | $156.07 | Not published | — |
| TGTX | TG Therapeutics Inc | $53.16 | $52.59 | -1.1% |
| ARWR | Arrowhead Pharmaceuticals Inc | $59.89 | $51.45 | -14.1% |
| ABVX | Abivax SA American Depositary Shares | $90.23 | Not published | — |
| IONS | Ionis Pharmaceuticals Inc | $43.91 | Not published | — |
| PRAX | Praxis Precision Medicines Inc | $258.92 | Not published | — |
| IOVA | Iovance Biotherapeutics Inc | $14.14 | Not published | — |
| RYTM | Rhythm Pharmaceuticals Inc | $90.90 | Not published | — |
| BLTE | Belite Bio Inc ADR | $150.27 | Not published | — |
| LGND | Ligand Pharmaceuticals Incorporated | $307.82 | $246.61 | -19.9% |
| IMVT | Immunovant Inc | $29.10 | Not published | — |
| KOD | Kodiak Sciences Inc | $85.78 | Not published | — |
| MIRM | Mirum Pharmaceuticals Inc | $83.10 | $72.54 | -12.7% |
| CGON | CG Oncology, Inc. Common stock | $62.54 | Not published | — |
| COGT | Cogent Biosciences Inc | $31.31 | Not published | — |
| ORKA | Oruka Therapeutics, Inc. | $81.15 | Not published | — |
| PTCT | PTC Therapeutics Inc | $63.04 | Not published | — |
| ERAS | Erasca Inc | $14.04 | Not published | — |
| SRRK | Scholar Rock Holding Corp | $41.96 | Not published | — |
| TVTX | Travere Therapeutics Inc | $52.43 | $46.33 | -11.6% |
| CRSP | Crispr Therapeutics AG | $49.99 | Not published | — |
| DFTX | Definium Therapeutics, Inc. | $36.00 | Not published | — |
| EWTX | Edgewise Therapeutics Inc | $39.99 | $47.64 | +19.1% |
| DNTH | Dianthus Therapeutics Inc. | $78.53 | Not published | — |
| TNGX | Tango Therapeutics Inc | $27.93 | Not published | — |
| ARQT | Arcutis Biotherapeutics Inc | $32.20 | $24.30 | -24.5% |
| RLAY | Relay Therapeutics, Inc. | $18.34 | Not published | — |
| ABCL | Abcellera Biologics Inc | $11.37 | Not published | — |
| TLX | Telix Pharmaceuticals Limited | $9.54 | $7.39 | -22.5% |
| LEGN | Legend Biotech Corp | $18.90 | $17.75 | -6.1% |
| ACAD | ACADIA Pharmaceuticals Inc | $20.31 | $25.79 | +27.0% |
| XENE | Xenon Pharmaceuticals Inc | $36.50 | Not published | — |
| IDYA | Ideaya Biosciences Inc | $36.12 | $30.08 | -16.7% |
| VKTX | Viking Therapeutics Inc | $25.83 | Not published | — |
| TARS | Tarsus Pharmaceuticals Inc | $72.08 | $66.21 | -8.1% |
| DYN | Dyne Therapeutics Inc | $15.77 | Not published | — |
| ELVN | Enliven Therapeutics Inc. | $41.93 | Not published | — |
| DNLI | Denali Therapeutics Inc | $18.66 | Not published | — |
| CELC | Celcuity LLC | $65.57 | Not published | — |
| IRON | Disc Medicine Inc. | $75.03 | Not published | — |
| NRIX | Nurix Therapeutics Inc | $25.51 | $24.73 | -3.1% |
| ZLAB | Zai Lab Ltd | $22.04 | $21.03 | -4.6% |
| MRVI | Maravai Lifesciences Holdings Inc | $7.07 | $6.35 | -10.2% |
| MBX | MBX Biosciences, Inc. Common Stock | $50.46 | Not published | — |
| BEAM | Beam Therapeutics Inc. | $24.56 | Not published | — |
| NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $21.58 | $18.19 | -15.7% |
| ADMA | ADMA Biologics Inc | $10.95 | $11.61 | +6.0% |
| SLS | Sellas Life Sciences Group Inc | $11.35 | Not published | — |
| PGEN | Precigen Inc | $6.39 | Not published | — |
| RCUS | Arcus Biosciences Inc | $19.36 | Not published | — |
| HRMY | Harmony Biosciences Holdings | $36.03 | $72.38 | +100.9% |
| AUPH | Aurinia Pharmaceuticals Inc | $17.32 | $20.87 | +20.5% |
| AGIO | Agios Pharm | $37.19 | Not published | — |
| PHVS | Pharvaris BV | $30.68 | Not published | — |
| FTRE | Fortrea Holdings Inc. | $23.92 | Not published | — |
| VERA | Vera Therapeutics Inc | $29.05 | Not published | — |
| IMNM | Immunome Inc | $18.26 | Not published | — |
| VCEL | Vericel Corp Ord | $42.97 | $23.97 | -44.2% |
| SRPT | Sarepta Therapeutics Inc | $18.18 | Not published | — |
| LKFT | Lakefront Biotherapeutics NV | $31.40 | Not published | — |
| RXRX | Recursion Pharmaceuticals Inc | $3.58 | Not published | — |
| ZYME | Zymeworks Inc. Common Stock | $28.44 | Not published | — |
| MLYS | Mineralys Therapeutics, Inc. Common Stock | $21.47 | Not published | — |
| NVAX | Novavax Inc | $9.99 | Not published | — |
| XNCR | Xencor Inc | $25.84 | $21.53 | -16.7% |
| ZBIO | Zenas BioPharma, Inc. Common Stock | $28.23 | Not published | — |
| TRVI | Trevi Therapeutics Inc | $12.94 | Not published | — |
| MAZE | Maze Therapeutics, Inc. Common Stock | $31.95 | Not published | — |
| PVLA | Palvella Therapeutics, Inc | $126.39 | Not published | — |
| BHVN | Biohaven Ltd. | $14.69 | Not published | — |
| STOK | Stoke Therapeutics Inc | $25.70 | $20.63 | -19.7% |
| URGN | UroGen Pharma Ltd | $35.15 | Not published | — |
| IMCR | Immunocore Holdings Ltd | $32.12 | $30.06 | -6.4% |
| NTLA | Intellia Therapeutics Inc | $11.16 | Not published | — |
| GPCR | Structure Therapeutics Inc. American Depositary Shares | $21.93 | Not published | — |
| MESO | Mesoblast Ltd | $12.55 | $12.38 | -1.4% |
| RARE | Ultragenyx | $15.95 | Not published | — |
| QURE | Uniqure NV | $23.11 | Not published | — |
| INVA | Innoviva Inc | $21.06 | $34.70 | +64.8% |
| AAPG | Ascentage Pharma Group International | $14.92 | Not published | — |
| OCUL | Ocular Therapeutix Inc | $6.61 | Not published | — |
| ORIC | Oric Pharmaceuticals Inc | $13.63 | Not published | — |
| KRSA | Korsana Biosciences, Inc. | $33.43 | Not published | — |
| RAPP | Rapport Therapeutics, Inc. Common Stock | $26.53 | Not published | — |
| TYRA | Tyra Biosciences Inc | $20.87 | Not published | — |
| INBX | Inhibrx Biosciences, Inc. | $97.10 | Not published | — |
| ANAB | AnaptysBio Inc | $48.10 | $48.15 | +0.1% |
| NKTR | Nektar Therapeutics | $38.65 | Not published | — |
| LBRX | LB Pharmaceuticals Inc Common Stock | $39.42 | $40.14 | +1.8% |
| GHRS | GH Research PLC | $18.50 | Not published | — |
| DMRA | Damora Therapeutics, Inc. | $21.71 | Not published | — |
| NBTX | Nanobiotix | $29.19 | Not published | — |
| SLN | Silence Therapeutics plc | $19.66 | Not published | — |
| BCAX | Bicara Therapeutics Inc. Common Stock | $17.61 | Not published | — |
| DRTS | Alpha Tau Medical Ltd | $12.90 | Not published | — |
| OMER | Omeros Corporation | $16.86 | $17.49 | +3.7% |
| SNDX | Syndax Pharmaceuticals Inc | $13.57 | Not published | — |
| IMTX | Immatics NV | $7.54 | Not published | — |
| REPL | Replimune Group Inc | $11.99 | Not published | — |
| JANX | Janux Therapeutics Inc | $17.06 | Not published | — |
| VOR | Vor Biopharma Inc | $18.94 | Not published | — |
| GLUE | Monte Rosa Therapeutics Inc | $11.11 | $9.57 | -13.9% |
| ANRO | Alto Neuroscience, Inc. | $22.20 | Not published | — |
| MGTX | MeiraGTx Holdings PLC | $9.77 | $9.63 | -1.4% |
| CGEM | Cullinan Oncology LLC | $14.92 | Not published | — |
| JBIO | Jade Biosciences, Inc. | $14.91 | Not published | — |
| AVBP | ArriVent BioPharma, Inc. Common Stock | $19.20 | Not published | — |
| MLTX | MoonLake Immunotherapeutics | $12.34 | Not published | — |
| RIGL | Rigel Pharmaceuticals Inc | $48.86 | $69.64 | +42.5% |
| KURA | Kura Oncology Inc | $9.86 | Not published | — |
| ALMS | Alumis Inc | $6.82 | Not published | — |
| CRVS | Corvus Pharmaceuticals Inc | $10.65 | Not published | — |
| VSTM | Verastem Inc | $10.06 | Not published | — |
| IMMX | Immix Biopharma Inc | $8.35 | Not published | — |
| SGMT | Sagimet Biosciences Inc. Series A Common Stock | $9.95 | $8.33 | -16.3% |
| PHAR | Pharming Group NV | $10.67 | $9.33 | -12.6% |
| SLDB | Solid Biosciences LLC | $6.19 | Not published | — |
| ANL | Adlai Nortye Ltd. American Depositary Shares | $10.58 | Not published | — |
| AURA | Aura Biosciences Inc | $6.46 | Not published | — |
| NVCT | Nuvectis Pharma Inc | $20.89 | Not published | — |
| ACHV | Achieve Life Sciences Inc | $6.50 | Not published | — |
| DNA | Ginkgo Bioworks Holdings | $9.71 | Not published | — |
| CADL | Candel Therapeutics Inc | $8.38 | Not published | — |
| GYRE | Gyre Therapeutics Inc. | $5.86 | $4.63 | -21.0% |
| SVA | Sinovac Biotech Ltd | $6.47 | Not published | — |
| OLMA | Olema Pharmaceuticals Inc | $7.02 | Not published | — |
| ZVRA | Zevra Therapeutics Inc. | $10.33 | $17.25 | +67.0% |
| CLYM | Climb Bio Inc | $10.54 | Not published | — |
| STTK | Shattuck Labs Inc | $5.60 | Not published | — |
| DBVT | DBV Technologies | $9.68 | Not published | — |
| PHAT | Phathom Pharmaceuticals Inc | $7.02 | Not published | — |
| CRMD | CorMedix Inc | $8.10 | $20.95 | +158.6% |
| PBYI | Puma Biotechnology Inc | $11.26 | $16.27 | +44.5% |
| DRUG | Bright Minds Biosciences Inc | $52.69 | Not published | — |
| VALN | Valneva SE ADR | $5.36 | Not published | — |
| FTH | Faeth Therapeutics, Inc. | $20.10 | Not published | — |
| NGNE | Neurogene Inc | $24.28 | Not published | — |
| EPRX | Eupraxia Pharmaceuticals Inc. Common Stock | $7.61 | Not published | — |
| MNPR | Monopar Therapeutics Inc | $72.58 | Not published | — |
| ARVN | Arvinas Inc | $7.72 | $9.22 | +19.4% |
| RGNX | Regenxbio Inc | $7.17 | Not published | — |
| CBIO | Crescent Biopharma, Inc. | $13.14 | Not published | — |
| DMAC | DiaMedica Therapeutics Inc | $8.63 | Not published | — |
| OCS | Oculis Holding AG Ordinary shares | $8.09 | Not published | — |
| PRTA | Prothena Corporation plc | $8.25 | Not published | — |
| ASMB | Assembly Biosciences Inc | $20.28 | $19.89 | -1.9% |
| TECX | Tectonic Therapeutic, Inc. | $21.09 | Not published | — |
| YDES | YD Bio Ltd | $4.24 | Not published | — |
| CAPR | Capricor Therapeutics Inc | $6.13 | $5.09 | -17.0% |
| KYTX | Kyverna Therapeutics, Inc. Common Stock | $5.73 | Not published | — |
| FENC | Fennec Pharmaceuticals Inc | $10.32 | $8.85 | -14.2% |
| ENTA | Enanta Pharmaceuticals Inc | $11.62 | Not published | — |
| ARCT | Arcturus Therapeutics Holdings Inc | $10.73 | Not published | — |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | $8.39 | $7.02 | -16.4% |
| TTRX | Turn Therapeutics Inc. Common Stock | $10.18 | Not published | — |
| ARTV | Artiva Biotherapeutics, Inc. Common Stock | $6.20 | Not published | — |
| BNTC | Benitec Biopharma Inc. | $8.82 | Not published | — |
| SRZN | Surrozen Inc | $25.75 | Not published | — |
| AGEN | Agenus Inc | $6.51 | $11.28 | +73.3% |
| QTTB | Q32 Bio Inc | $8.80 | $9.92 | +12.7% |
| GLSI | Greenwich Lifesciences Inc | $15.57 | Not published | — |
| RNAC | Cartesian Therapeutics Inc. | $6.41 | Not published | — |
| STRO | Sutro Biopharma | $10.29 | Not published | — |
VRTX vs REGN · VRTX vs ARGX · VRTX vs ONC · VRTX vs RPRX · VRTX vs ALNY · REGN vs ARGX · REGN vs ONC · REGN vs RPRX · REGN vs ALNY · ARGX vs ONC · ARGX vs RPRX · ARGX vs ALNY · ONC vs RPRX · ONC vs ALNY · RPRX vs ALNY
All industries · Compare any two stocks · Intrinsic Value Calculator